Advancing Pharmacogenomics as a Component of Precision Medicine: How, Where, and Who? - Wikidata - wikimedia - TriplyDB

Advancing Pharmacogenomics as a Component of Precision Medicine: How, Where, and Who?

Advancing Pharmacogenomics as a Component of Precision Medicine: How, Where, and Who?

http://www.wikidata.org/entity/Q36493991

about

Challenges and strategies for implementing genomic services in diverse settings: experiences from the Implementing GeNomics In pracTicE (IGNITE) network How close are we to individualized medicine for Parkinson's disease?Precision Medicine at the University of Alabama at Birmingham: Laying the Foundational Processes Through Implementation of Genotype-Guided Antiplatelet Therapy.Integrating pharmacogenomics into electronic health records with clinical decision support.Pharmacogenomics competencies in pharmacy practice: A blueprint for change.Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing.Precision Medicine-Nobody Is Average.Pharmacists should jump onto the clinical pharmacogenetics train.

P2860

Q33717221-E89F8F58-59EB-4AD2-B01D-3584A74DCFB5 Q38814888-04375889-500A-4562-AD37-3B148D622E3F Q38998163-3B919953-A597-4D2B-AB5E-0ED034E955B1 Q39173300-CF48A721-1B20-458C-A70B-1A5AA87D6794 Q39212511-1559D55F-5952-4FD1-942B-AC0E17713B8A Q47428539-371054C0-DE28-43BA-9576-47268404C07C Q53508013-55015DB1-3655-425C-83B2-70E951F0E9D8 Q55229236-A31AF4B9-43AF-4945-8764-A2240F6BC249

P2860

Advancing Pharmacogenomics as a Component of Precision Medicine: How, Where, and Who?

http://www.wikidata.org/entity/Q36493991

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Advancing Pharmacogenomics as a Component of Precision Medicine: How, Where, and Who?

@ast

Advancing Pharmacogenomics as a Component of Precision Medicine: How, Where, and Who?

@en

type

label

Advancing Pharmacogenomics as a Component of Precision Medicine: How, Where, and Who?

@ast

Advancing Pharmacogenomics as a Component of Precision Medicine: How, Where, and Who?

@en

prefLabel

Advancing Pharmacogenomics as a Component of Precision Medicine: How, Where, and Who?

@ast

Advancing Pharmacogenomics as a Component of Precision Medicine: How, Where, and Who?

@en

P1433

Q36493991-FD0644F4-123D-4336-B2F9-6DBAE71757F8

P1476

Q36493991-D177571B-EC71-4FD2-A127-919BCC0F0763

P2093

Q36493991-24A0C1E0-67F4-40F4-BD4A-3B1CA341CB49

Q36493991-DE822BD3-05FA-4EB4-8E89-35AC169F1038

P2860

Q36493991-10AEA16A-64B7-4F69-8D73-22D7F4C9B724

Q36493991-1E180357-4262-4A5E-BEBB-49AF45D2BAD9

Q36493991-1E41ACBE-8CA5-4B75-A170-C356FBDB670B

Q36493991-3784D74E-94A7-4B1A-A889-E139666B0CB7

Q36493991-6F96A781-B566-4339-B4DA-4E1ED59AA376

Q36493991-93B65EF4-FA69-455B-A0CB-70ABD8042537

Q36493991-EE4F27A9-B0F7-4E80-9670-72C2C2DBDA39

Q36493991-EF85D533-5438-491C-87FE-18F4B4880165

P304

Q36493991-7C201335-6CF4-4728-952A-A99B77F8FC53

P31

Q36493991-97671BD1-DB32-43B9-8485-BD6942B9B34F

P356

Q36493991-727B68F5-D284-4F6F-9ED8-48697E1A063E

P407

Q36493991-822D607E-1D7D-4ED4-BF36-4357186FA64E

P433

Q36493991-7A505B9C-B3F9-4678-B277-F8D72E02D01D

P478

Q36493991-BDB964A2-60BB-4BE9-8F39-6D17EBD740FE

P577

Q36493991-C3110EDE-19F7-4A82-A58B-D16063E00440

P698

Q36493991-87D13041-F71F-4997-B196-6311C66A8866

P921

Q36493991-E27C0121-7D6B-4530-9DE2-57182F653B34

P932

Q36493991-479CD690-E118-4357-A0A2-ED874B6A632B

P356

P1433

Clinical Pharmacology & Therapeutics

P1476

Advancing Pharmacogenomics as a Component of Precision Medicine: How, Where, and Who?

@en

P2093

J A Johnson

http://www.w3.org/2001/XMLSchema#string

K W Weitzel

http://www.w3.org/2001/XMLSchema#string

P2860

Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting.

Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation.

ASHP national survey of pharmacy practice in hospital settings: Dispensing and administration--2014.

The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia.

Implementation of a pharmacogenomics service in a community pharmacy.

Postdischarge community pharmacist-provided home services for patients after hospitalization for heart failure.

Effect of a Community Pharmacist–Delivered Diabetes Support Program for Patients Receiving Specialty Medical Care

P304

154-156

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CPT.273

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26440500

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics

P932

4724232

http://www.w3.org/2001/XMLSchema#string